MeTA in Peru

DR. MELITON ARCE RODRIGUEZ

VICE MINISTRO DE SALUD

(on behalf of the Peruvian Delegation)

16/05/2008

16/05/2008

Basic info about MeTA in Peru

Just beginning the process! – First visit from a MeTA representative in April, 2007– Beginning of conversations with local MeTA representative

in November, 2007– Health Minister Hernan Garrido-Lecca signed on formally

to MeTA in March, 2008

16/05/2008

Key Issues

Universal access independently of economy, social class, geography, race or ethnicity

Provision of safe and efficient medicines, including quality control

National essential medicines list which is unified and current

Permanent updating of technology for medicines Promote the use of generic drugs

04/13/23

Machu Picchu: One of the Seven Wonders of the World!

16/05/2008

Transparency & Accountability

Some Current Areas of Work – Observatory in Medicines

DIGEMID y AIS (HAI)

– Defensoria del Pueblo A report regarding the system for supply of medicines in public

sector Responding to demands regarding public services

16/05/2008

Transparency and Accountability– Consejo Nacional de Salud

A body which drives the national health system Minister of Health presides Multisectoral in 19 different topics, including medicines: public, private

health providers as well as civil society (11 institutions participate) Consultation and consensus-building body on public policies in health

– ForoSalud Participation of civil society in vigilence of medicines access and quality Regional tables working specifically on medicines access in a number of

regions of the country Has a seat on the Consejo Nacional de Salud and brings to Table issues

raised regionally

16/05/2008

MeTA structures in Peru

Early stages of the process– Our task force (delegation) is discussing how best to

structure Interest in the some possible structures

– Secretaria Ejecutiva– Multistakeholder approach – Development of a national workplan– Ministry of Health as champion and chair of the process

16/05/2008

Main areas of work for MeTA

Issues of supply – overstock and understock Issue of quality of medicines:

– Lax medicines registration– Quality control– Create a better capacity for the state to regulate medicines – More autonomy for the drug regulatory office (DIGEMID)– Lax prescription and dispensation

Fragmented public health system

Main areas of work for MeTA Need to unify national essential essential medicines list (each sector

has its own…police, army, marines, airforce, Health Ministry, and social security ESSalud)

Illegal medicines (contraband, counterfeit, adulturated, expired, stolen) Evaluate options regarding public private partnerships to fill the gaps

of the needs of most of the population to receive their medicines Need to permanently review the process for the acquisition of

medicines– Corporate purchases– Reverse auction– Quality control– Technical files

04/13/23

04/13/23

National research needs Price differentials for consumers in different parts of the country Evaluation of work that has been done regarding improving the efficacy of the public supply

chain Better understanding of consumer access through public systems A look at the causes of self medication How to promote appropriate prescriptions Factors (or not) that promote the rational use of medicines A look at how pharmaceuticals influence on the prescriptors and dispensers Need to unify national essential essential medicines list (each sector has its own…police,

army, marines, airforce, Health Ministry, and social security ESSalud) Illegal medicines (contraband, counterfeit, adulturated, expired, stolen) Evaluate options regarding public private partnerships to fill the gaps of the needs of most of

the population to receive their medicines Understand the practice of traditional healers outside of the the formal medical

establishment. Harmonizing the policies among the different insititutions specifically with regard to

medicines acquisition, etc.

16/05/2008

Lessons learned so far…

Importance of a multistakeholder approach Necessary to create alliances with other actors

working in health Importance of public-private partnership Value of learning regarding the global experiences in

the MeTA

Challenges, risks The need for public policies to be sustainable Preserve the global accords WHO and Doha Implementation of Free Trade Agreement (FTA) with the United

States, assuring that it does not bring down standards regarding patents and second patents

Current debate a new medicines law in Congress which would guarantee universal access to safe, efficient and quality medicines through the strengthening of the national medicines regulator (to be approved this year).

Even though there are mechanisms that are being developed for transparency, these must be more efficient

04/13/23

Support needs?

Support for a local technical secretariat to organize a national forum

Financial support needs to implement a national workplan

Strengthen system of vigilence for civil society– Help to sustain and institutionalize networks– Capacities for advocacy

Create technical capacities Networking opportunities with other MeTA pilot sites

13/04/23

Thank you!Vice Minister of Health

Dr.Elias Meliton Arce Rodriguez

marcer@minsa.gob.pe

www.minsa.gob.pe

Members of Peru Delegation:

Dr. Julio Castro, Dean of the College of Physicians of Peru

Dr. Victor Dongo, General Director, DIGEMID

Mr. Edson Meza, Associate, Health Action International

Ing. Augusto Rey, Executive Director, ALAFARPE

Dra. Susana Silva, Legal Advisor, National Ombudsman’s Office

04/13/23